New stem cell filter aims to reduce transplant complications for rare blood diseases
NCT ID NCT06731036
First seen Feb 23, 2026 · Last updated May 16, 2026 · Updated 14 times
Summary
This expanded access program offers a special stem cell filtering technique (CD34+ selection) to patients with severe blood disorders like sickle cell disease and immune deficiencies. The goal is to lower the risk of graft-versus-host disease, a serious complication where donor cells attack the patient's body. Eligible patients include those receiving stem cell transplants for non-malignant conditions or needing stem cell boosts.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.